AG00IABB

58-32-2 | 2-({6-[bis(2-hydroxyethyl)amino]-4,8-bis(piperidin-1-yl)pyrimido[5,4-d][1,3]diazin-2-yl}(2-hydroxyethyl)amino)ethan-1-ol

AG00IABB

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	58-32-2
Catalog Number	AG00IABB(AGN-PC-0SPNC7)
Chemical Name	2-({6-[bis(2-hydroxyethyl)amino]-4,8-bis(piperidin-1-yl)pyrimido[5,4-d][1,3]diazin-2-yl}(2-hydroxyethyl)amino)ethan-1-ol
EC Number	200-374-7
IUPAC Name	2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
InChI	InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2
InChI Key	IZEKFCXSFNUWAM-UHFFFAOYSA-N
MDL Number	MFCD00010555
Molecular Formula	C24H40N8O4
Molecular Weight	504.6256
SMILES	OCCN(CCO)C1=NC(N2CCCCC2)=C(N=C(N(CCO)CCO)N=C3N4CCCCC4)C3=N1
UNII	64ALC7F90C
Synonyms	Antistenocardin, Apo Dipyridamole, Apo-Dipyridamole, Cerebrovase, Cléridium, Curantil, Curantyl, Dipyramidole, Dipyridamole, Kurantil, Miosen, Novo Dipiradol, Novo-Dipiradol, Persantin, Persantine, dipyridamole, 58-32-2, Dipyridamine, Dipyridamol, Persantin, Dipyudamine, Persantine, Curantyl, Stimolcardio, Kurantil, Stenocardil, Cardioflux, Dipiridamol, Dipyridan, Peridamol, Anginal, Apricor, Coribon, Corosan, Coroxin, Stenocardiol, Agilease, Chilcolan, Justpertin, Permiltin, Piroan, Cleridium 150, Coronarine, Gulliostin, Prandiol, Natyl, Prandiol 75, Usaf Ge-12, Dypyridamol, Cleridium, Iv Persantine, Dipyridamolum, Cardoxil, RA 8, 2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol, RA-8, Dypyridamole, Coridil, Protangix, Dipiridamol [INN-Spanish], Dipyridamolum [INN-Latin], Permole, Dipyridamole (Persantine), UNII-64ALC7F90C, Aggrenox, NSC 515776, MLS000028420, C24H40N8O4, EINECS 200-374-7, CHEMBL932, NSC-515776, 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine, BRN 0068373, SMR000058382, 64ALC7F90C, CHEBI:4653, 2-({6-[bis(2-hydroxyethyl)amino]-4,8-bis(piperidin-1-yl)pyrimido[5,4-d][1,3]diazin-2-yl}(2-hydroxyethyl)amino)ethan-1-ol, IZEKFCXSFNUWAM-UHFFFAOYSA-N, Pyrimido(5,4-d)pyrimidine, 2,6-bis(bis(2-hydroxyethyl)amino)-4,8-dipiperidino-, MFCD00010555, NSC515776, Ethanol, 2,2',2'',2'''-[(4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakis-, CAS-58-32-2, NCGC00015385-12, Antistenocardin, Dipyramidole, Curantil, 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine, Novo-Dipiradol, 2,2',2'',2'''-((4,8-Dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetraethanol, DSSTox_CID_20668, DSSTox_RID_79531, DSSTox_GSID_40668, 2,2',2'',2'''-((4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetrakis(ethan-1-ol), 2,2',2'',2'''-{[4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilo}tetraethanol, 2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol, Ethanol, 2,2',2'',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-, Persantine (TN), 2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethano, 2-({6-[bis(2-hydroxyethyl)amino]-4,8-bis(piperidin-1-yl)-[1,3]diazino[5,4-d]pyrimidin-2-yl}(2-hydroxyethyl)amino)ethan-1-ol, 2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidyl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol, Ethanol, 2,2',2'',2'''-((4,8-dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetra-, Apo-Dipyridamole Fc, Apo-Dipyridamole Sc, SR-01000003065, Dipyridamole [USAN:INN:BAN:JAN], Dipridacot, Prestwick_145, Dipyridamole [USAN:USP:INN:BAN:JAN], Spectrum_001004, Tocris-0691, Opera_ID_494, AC1Q7CXU, AC1Q7CXW, AC1Q7CXX, Prestwick0_000142, Prestwick1_000142, Prestwick2_000142, Prestwick3_000142, Spectrum2_000972, Spectrum3_000402, Spectrum4_000522, Spectrum5_000839, Lopac-D-9766, UPCMLD-DP072, D 9766, AC1L1F6T, cid_3108, Permole;Dipyridan;Persantine, Lopac0_000464, SCHEMBL16119, BSPBio_000244, BSPBio_001554, BSPBio_001924, KBioGR_001123, KBioSS_001484, 4-26-00-03840 (Beilstein Handbook Reference), MLS001076306, MLS001333724, MLS002548866, DivK1c_000696, SPECTRUM1500259, SPBio_001003, SPBio_002183, BPBio1_000270, GTPL4807, DTXSID6040668, Thymidine,6-dihydro-6-methoxy-, UPCMLD-DP072:001, BDBM23620, CTK8B5592, Dipyridamole (JP17/USP/INN), HMS502C18, IZEKFCXSFNUWAM-UHFFFAOYSA-, KBio1_000696, KBio2_001484, KBio2_004052, KBio2_006620, KBio3_001144, KS-00000KNA, Dipyridamole(Permole,-Persantine), NINDS_000696, BCPP000256, HMS1568M06, HMS1791N16, HMS1920I10, HMS1989N16, HMS2089N15, HMS2091O18, HMS2095M06, HMS2232E19, HMS3259C03, HMS3261M10, HMS3266J17, HMS3371J03, HMS3402N16, HMS3655I20, HMS3675B03, HMS3712M06, Pharmakon1600-01500259, ZINC643046, BCP26947, EBD20789, HY-B0312, Tox21_110133, Tox21_500464, 2,6-Bis(diethanolamine)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine, ANW-49242, BBL027781, CCG-40190, NSC756743, s1895, STL377790, AKOS000509426, Tox21_110133_1, BCP9000613, CS-2352, DB00975, Dipyridamole, >=98% (TLC), powder, HS-0041, LP00464, MCULE-3112669573, MP-0582, NC00448, NSC-619103, NSC-756743, RTR-020274, VA10749, IDI1_000696, SMP2_000208, NCGC00015385-01, NCGC00015385-02, NCGC00015385-03, NCGC00015385-04, NCGC00015385-05, NCGC00015385-06, NCGC00015385-07, NCGC00015385-08, NCGC00015385-09, NCGC00015385-10, NCGC00015385-11, NCGC00015385-13, NCGC00015385-14, NCGC00015385-15, NCGC00015385-16, NCGC00015385-18, NCGC00023914-02, NCGC00023914-04, NCGC00023914-05, NCGC00023914-06, NCGC00023914-07, NCGC00023914-08, NCGC00023914-09, NCGC00023914-10, NCGC00023914-11, NCGC00261149-01, 4CA-0464, AC-18100, AJ-23813, AK-76609, AN-23600, BAS 00818792, BC213273, BR-76609, CJ-04389, CPD000058382, H843, LS-66732, NCI60_005689, SAM002264609, SC-18455, ST078856, ZB014732, SBI-0050449.P004, 2,8-dipiperidinopyrimido[5,4-d]pyrimidine, AB0013300, AB2000355, ST2415551, AB00051974, B1933, D2274, EU-0100464, FT-0603242, SW196456-3, W1467, EN300-70723, BIM-0050449.0001, D00302, J10379, 54290-EP2277865A1, 54290-EP2298773A1, 54290-EP2305653A1, 54290-EP2308562A2, AB00051974-18, AB00051974-19, AB00051974_20, AB00051974_21, 58-32-2,763-39-4(XHCl), A828156, SR-01000003065-2, SR-01000003065-4, SR-01000003065-5, SR-01000003065-7, W-105400, BRD-K86301799-001-04-1, BRD-K86301799-001-19-9, BRD-K86301799-001-24-9, Z1259192074, Dipyridamole, British Pharmacopoeia (BP) Reference Standard, Dipyridamole, European Pharmacopoeia (EP) Reference Standard, Dipyridamole, United States Pharmacopeia (USP) Reference Standard, Pyrimido(5, 2,6-bis[bis(2-hydroxyethyl)amino]-4,8-diperidino-, 2,2'',2'''-[4,8-Dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilotetraethanol, 2,2',2'',2'''-(4,8-Dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilotetraethanol, 2,2',2',2'''-((4,8-Dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetraethanol, 2-[[2-(bis(2-hydroxyethyl)amino)-4,8-di(piperidin-1-yl)pyrimido[6,5-e]pyrimidin-, Dipyridamole for peak identification, European Pharmacopoeia (EP) Reference Standard, Ethanol,2',2'',2'''-(4,8-dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetra-, WLN: T66 BN DN GN INJ CCN HCN E- AT6NTJ B2Q F2Q& J- AT6NTJ B2Q F2Q, 2,2 ,2 ,2 -(4,8-Dipiperidino- pyrimido [5,4-d] pyrimidine-2,6- diyldinitrilotetraethanol, 2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]-pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol, 2,2',2'',2'''-(4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl)tetraethanol, 2,2',2'',2'''-(4,8-Dipiperidino-pyrimido [5,4-d] pyrimidine-2,6-diyldinitrilotetraethanol, 2,2',2'',2'''-[(4,8-dipiperidin-1-ylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol, 2,2',2'',2'''-[(4,8-Dipiperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol, 2,2',2'',2'''-[(4,8-Dipiperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakisethanol, 2-({6-[bis(2-hydroxyethyl)amino]-4,8-dipiperidylpyrimidino[5,4-d]pyrimidin-2-y l}(2-hydroxyethyl)amino)ethan-1-ol, 2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidinyl)-6-pyrimido[5,4-d]pyrimidinyl]-(2-hydroxyethyl)amino]ethanol, 2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol;, Ethanol, 2,2',2'',2'''-(4,8-dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyldinitrilo)tetra-, Ethanol, 2,2',2',2'''-((4,8-di-1-iperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-, Ethanol, 2,2',2',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-, Ethanol,2',2'',2'''-[(4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakis-, Ethanol,2',2'',2'''-[(4,8-dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetra-, Ethanol,2,2',2'',2'''-[(4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakis-, InChI=1/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2, Cardoxin, chlorpromazine, Cerebrovase, Miosen, Apo-Dipyridamole, Coronarin E, Danusertib, Novo Dipiradol, Apo Dipyridamole, D0F9GE, Apotex Brand of Dipyridamole, Belmac Brand of Dipyridamole, IPRAD Brand of Dipyridamole, Ashbourne Brand of Dipyridamole, Novopharm Brand of Dipyridamole, Dipyridamole (JP15/USP/INN), C20H28O, CID3108, Berlin Chemie Brand of Dipyridamole, Berlin-Chemie Brand of Dipyridamole, Dipyridamole [USAN:BAN:INN:JAN], NSC619103, C24-H40-N8-O4, CS-O-00564, Boehringer Ingelheim Brand of Dipyridamole, Permole, Persantine, Dipyridan, Dipyridamole, A10319, D004176, 50-53-3, Dipyridamole, 98%, a phosphodiesterase inhibitor - 100G 100g, 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido-[5,4-d]pyrimidine, N(CCO)(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO, (R)-N-(5-(2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide, 117591-81-8, 827318-97-8, DPM, Etanol, 2,2', 2'', 2'''-[(4,8-di-1-piperidinilpirimido [5,4-d] pirimidina-2,6-diil) dinitrilo tetraquis]-, Ethanol, 2,2',2'',2'''-[(4,8-di-1- piperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo ]tetrakis-,

Complexity	561
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	504.317g/mol
Formal Charge	0
Heavy Atom Count	36
Hydrogen Bond Acceptor Count	12
Hydrogen Bond Donor Count	4
Isotope Atom Count	0
Molecular Weight	504.636g/mol
Monoisotopic Mass	504.317g/mol
Rotatable Bond Count	12
Topological Polar Surface Area	145A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	0.7

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number